Clinical bottom line
Myofascial release therapy (MFR) is a manual therapy technique increasingly used in physical medicine and rehabilitation to address chronic musculoskeletal pain and functional impairment. Emerging evidence suggests MFR may reduce pain intensity and improve function in conditions such as fibromyalgia, chronic neck pain, and pelvic myofascial pain. However, effect sizes vary, and the quality of evidence remains limited by small sample sizes and heterogeneous protocols. MFR may be considered as an adjunctive intervention within a multidisciplinary rehabilitation program, but further high-quality trials are needed to clarify optimal dosing, long-term benefits, and comparative effectiveness against other manual therapies.
What the evidence shows
Several studies have investigated the efficacy of MFR in chronic musculoskeletal conditions. Liptan et al. (2013) conducted a pilot study comparing MFR to Swedish massage in fibromyalgia patients, finding that MFR produced greater reductions in pain and tender point sensitivity, suggesting a potential role in fibromyalgia symptom management. Shewail et al. (2023) performed a randomized clinical trial comparing instrument-assisted soft tissue mobilization with MFR in chronic neck pain, reporting that both interventions improved pain and disability, but MFR showed a trend toward superior functional outcomes.
In chronic pelvic pain, Kumar Rupali et al. (2025) highlight MFR as a key component in managing myofascial pelvic pain, emphasizing its role in releasing fascial restrictions and improving pelvic floor muscle function. Similarly, Sorrell and Sorrell (2003) describe a multidisciplinary protocol incorporating MFR for chronic resistant myofascial pain, reporting symptomatic improvements though acknowledging the need for controlled trials.
A recent comparative study by Sukhwal et al. (2025) examined high-intensity laser therapy combined with MFR versus ultrasound therapy with MFR in chronic heel pain among amateur badminton players. Both groups improved, but the laser plus MFR group showed greater pain reduction and functional gains, suggesting potential synergistic effects when MFR is combined with other modalities.
Bokarius et al. (2010) provide an evidence-based review of manual therapies, including MFR, concluding that while manual therapies can be effective for chronic musculoskeletal pain, the heterogeneity of study designs and outcome measures limits definitive conclusions. Hong and Simons (2004) also discuss MFR within the broader context of myofascial pain therapy, underscoring the importance of individualized treatment plans.
Caveats and uncertainty
Despite promising findings, the evidence base for MFR in chronic musculoskeletal conditions has several limitations. Many studies are small pilot or single-center trials with limited sample sizes, reducing statistical power and generalizability. Protocols for MFR vary widely in terms of duration, frequency, and technique, complicating comparisons and synthesis. Blinding is challenging in manual therapy trials, increasing risk of performance and detection bias.
Long-term follow-up data are sparse, so the durability of MFR benefits remains uncertain. Comparative effectiveness versus other manual therapies or exercise-based interventions is inadequately studied. Patient populations are heterogeneous, and subgroup analyses to identify responders versus non-responders are lacking. Additionally, the mechanisms by which MFR may reduce pain and improve function are not fully elucidated, warranting further mechanistic research.
How this may change practice
Physical medicine and rehabilitation clinicians may consider incorporating MFR as part of a multimodal approach for patients with chronic musculoskeletal pain syndromes, especially when conventional therapies have been insufficient. MFR could be integrated alongside exercise, education, and other manual therapies to potentially enhance pain relief and functional recovery.
Clinicians should remain cautious about overgeneralizing benefits given current evidence limitations and tailor MFR application to individual patient presentations and preferences. Monitoring patient response and adjusting treatment plans accordingly is advisable. Collaboration with multidisciplinary teams may optimize outcomes, particularly in complex cases such as fibromyalgia or chronic pelvic pain.
Future practice may be informed by ongoing research clarifying optimal MFR protocols, patient selection criteria, and integration with adjunctive therapies. Until then, MFR represents a promising but still investigational tool warranting further validation.